Program Highlights 2019

Download our program as a PDF or log in to our mobile event app to edit your personal schedule.

Main Topics

  • Clinical Trials
  • Artificial Intelligence in Healthcare
  • New Findings of Drug Actions / Repurposing
  • Investment Models from around the the Globe



  • Need-Led Innovation in Practice: How to develop an entrepreneurial mindset in the health sector, Hosted by:  Ursula Mühle, Director of Education, EIT Health Munich, Germany and Daniel Mogefors, University of Oxford, UK 
  • Understanding Healthcare and Hospitals – what innovators and founders need to know to succeed in the world of rules and regulation in Germany. A perspective from consulting experts, Hosted by: Saskia Gleitsmann and Nora Fuhrmann, WMC Healthcare Munich, Germany
  • Lessons learned from the fundraising trenches: the good, the bad and the ugly
    Hosted by: Charlie Cameron, Cooley LLP Boston, MA and John Hession, Morse Barnes-Brown Pendleton, Waltham, MA, US
  • What are the challenges faced by digital health start-ups from an idea to a company? :
    A short insight from an investor’s perspective. Hosted by: Lena Krzyzak and Philipp Rittershaus, High-Tech Gründerfonds Management GmbH 


    Confirmed Speakers

    Program and speakers are subject to change without notice.

    • Alberto Betella,CTO, Health Moonshot at Telefonica Alpha, Barcelona, Spain
    • Arthur L. Caplan, Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, New York, US  
    • Evan Castiglia, Senior Associate, Philips Health Technology Ventures, Amsterdam, NL
    • Ioana Cristea, Research Affiliate, Meta Research Innovation Center at Stanford, US
    • Eyal Gura, Co-Founder & CEO, Zebra Medical, Israel
    • John Hallinan, CBO MassBio, US
    • Michael Hemann, MIT Koch Institute for Integrated Cancer Research, Associate Professor of Biology, Cambridge, MA, US
    • Vincent Hennemand, VP, Strategy, Corporate and Business Development, Head of Immuno-Inflammation Program Unit Akili Interactive Labs, Boston, MA, US 
    • John Hession, Morse Barnes-Brown Pendleton, Waltham, MA,US
    • Dianne Jackson-Matthews, Adjunct Associate Professor UQ Centre for Clinical Research, The University of Queensland, AUS
    • Stephen Kennedy Smith, Kennedy Family Office, US
    • Heyo K. Kroemer, Chairman of the Managing Board of the University Medical Center Göttingen, Dean of the Faculty of Medicine, Georg‐August‐Universität Göttingen, Germany
    • Gottfried Ludewig, Head of the Department for Digitization of Health Care at the Federal Ministry of Health, Berlin, Germany
    • Travis McCready, President of the Massachusetts Life Sciences Center and Representative of the Commonwealth of Massachusetts, US
    • Keith McNeil, Assistant Deputy Director‐General and CCIO, Queensland Health, Australia
    • Mark H. Michalski, MD, Executive Director MGH & BWH Center for Clinical Data Science Harvard Medical School, Boston, MA, US 
    • Elizabeth O’Day, CEO & Founder, Olaris Therapeutics, Boston, MA, US
    • Nektarios Oraiopoulos, Director of the MPhil in Strategy, Marketing & Operations Programme, Cambridge Judge Business School, Cambridge, UK
    • Moshe Rogosnitzky, Founder and CEO of DRG - Drug Rediscovery Group Ltd, Israel
    • Armin Schneider, SVP, Scientific & Medical Affairs Pharma & Biotech, Molecular Health, Heidelberg, Germany
    • Aviad Tamir, Head of Life Sciences & Healthcare at Invest in Israel, Israel
    • Deborah Wake, CEO and Chief Medical Officer, MyWay Digital Health, Dundee, UK 
    • Andrew Whittaker, Biopharmaceuticals, Clinical Compound Bank Lead, AstraZeneca Pharmaceuticals, Melbourn, UK